Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pharming Group (PHAR)
NASDAQ:PHAR
Pharming Group (PHAR) Stock Price & Analysis
77 Followers
PHAR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.70 - $16.71
Previous Close$10.17
Volume1.98K
Average Volume (3M)2.75K
Market Cap
$704.32M
Enterprise Value$662.44M
Total Cash (Recent Filing)€213.42M
Total Debt (Recent Filing)€171.54M
Price to Earnings (P/E)-65.7
Beta0.71
Next Earnings
May 08, 2024EPS Estimate
<$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares Outstanding67,107,324
10 Day Avg. Volume2,227
30 Day Avg. Volume2,746
Standard Deviation0.14
R-Squared0.00286
Alpha-0.00221
Financial Highlights & Ratios
Price to Book (P/B)4.90
Price to Sales (P/S)2.78
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$37.00Price Target Upside263.82% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Pharming Group News
PremiumCompany Announcements
Pharming Group Lauded for Rare Disease Treatment
PremiumCompany Announcements
Pharming Completes Trial Enrollment for Pediatric Drug
PremiumCompany Announcements
Pharming Group Files Annual Report, Sets AGM Date
Ownership Overview
0.00%
Insiders
<0.01% Mutual Funds
0.03% Other Institutional Investors
99.97% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PHAR FAQ
What was Pharming Group’s price range in the past 12 months?
Pharming Group lowest stock price was $9.70 and its highest was $16.71 in the past 12 months.
What is Pharming Group’s market cap?
Currently, no data Available
When is Pharming Group’s upcoming earnings report date?
Pharming Group’s upcoming earnings report date is May 08, 2024 which is in 13 days.
How were Pharming Group’s earnings last quarter?
Pharming Group released its earnings results on Mar 14, 2024. The company reported -$0.04 earnings per share for the quarter, missing the consensus estimate of $0.004 by -$0.044.
Is Pharming Group overvalued?
According to Wall Street analysts Pharming Group’s price is currently Undervalued.
Does Pharming Group pay dividends?
Pharming Group does not currently pay dividends.
What is Pharming Group’s EPS estimate?
Pharming Group’s EPS estimate is <$0.01.
How many shares outstanding does Pharming Group have?
Pharming Group has 67,107,320 shares outstanding.
What happened to Pharming Group’s price movement after its last earnings report?
Pharming Group reported an EPS of -$0.04 in its last earnings report, missing expectations of $0.004. Following the earnings report the stock price went down -1.71%.
Which hedge fund is a major shareholder of Pharming Group?
Currently, no hedge funds are holding shares in PHAR
---
Pharming Group Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$37.00 (263.82% Upside)
$37.00 (263.82% Upside)
Blogger Sentiment
Bullish
PHAR Sentiment 100%
Sector Average 70%
Sector Average 70%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.72%
12-Months-Change
Fundamentals
Return on Equity
-4.83%
Trailing 12-Months
Asset Growth
9.01%
Trailing 12-Months
Company Description
Pharming Group
Pharming Group is engaged in the development of products for the treatment of unmet medical needs. The company focuses on the development and production of human therapeutic proteins to provide life-changing solutions to patients. Its product includes Ruconest. Most of the revenue generated from the United States.
---
PHAR Company Deck
---
PHAR Earnings Call
Q4 2024
0:00 / 0:00
---
PHAR Stock 12 Months Forecast
Average Price Target
$37.00
▲(263.82% Upside)
Technical Analysis
---